Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2000
10/24/2000US6136600 Method for cultivation of hepatocytes
10/24/2000US6136598 Mus dunni endogenous retroviral packaging cell lines
10/24/2000US6136597 Nucleotide sequences comprising regulatory sequences for the efficient transferring of nucleic acid sequences to cytoplasm and expression of heterologous nucleic acids
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136594 Expression plasmid with defects in gene associated with propagation but which codes cystic fibrosis transmembrane conductance regulator; for gene therapy
10/24/2000US6136587 Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
10/24/2000US6136584 Joining polypeptide; for the development of and screening of therapy agents for autoimmune diseases
10/24/2000US6136581 Kinase genes and uses
10/24/2000US6136570 Method for producing RNA viruses from cDNA
10/24/2000US6136565 Methods of reducing the levels of protoporphyrin IX in recombinant hemoglobin preparations
10/24/2000US6136564 Process for the production of peptides by way of streptavidin fusion proteins
10/24/2000US6136563 With defined substitutions for enhanced affinity for its receptor
10/24/2000US6136562 Synthetic dna which encodes a peptide having a defined amino acid sequence; for recombinant production of the peptide for use in cattle; veterinary medicine
10/24/2000US6136561 Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems
10/24/2000US6136559 DNA encoding as human histamine receptor of the H3 subtype
10/24/2000US6136558 Having defined amino acid sequence not found in nature and capable of binding an erbb receptor; anticarcinogenic agents; treatment of muscular, epithelial, and nervous system disorders; diagnosis of cancer
10/24/2000US6136557 Strepococcus pneumoniae gene sequence FtsH
10/24/2000US6136556 TCTS response regulator
10/24/2000US6136552 High-affinity salicylic acid-binding protein and methods of use
10/24/2000US6136550 Dna which encodes the amino acid sequence of an alpha5 receptor; for drug screening of agonists and antagonists
10/24/2000US6136548 Mutating one or more amino acids of tissue plasminogen activator, then measuring binding of mutant to beta amyloid peptide and to fibrin; improved mutant binds fibrin but does not bind beta-amyloid peptide; for alzheimer's patients
10/24/2000US6136547 Amino acid sequences of glucose transporter x; for diagnosis and treatment of disorders associated with aberrant hexose transport; antibodies; probes; primers
10/24/2000US6136544 Amino acid sequence of unedited form of human excitatory amino acid 4 receptor subunit; for drug screening
10/24/2000US6136542 Method for screening for inhibitors and activators of type III secretion machinery in gram-negative bacteria
10/24/2000US6136539 Compositions and methods for the inhibition of MUC-5 mucin gene expression
10/24/2000US6136536 Recombinant dna sequence from plasmid phtop; for production in chinese hamster ovary cell lines
10/24/2000US6136528 Multiple sclerosis virus
10/24/2000US6136527 Polypeptides derived from proteins of the hepatitis C virus, test kits containing these polypeptides and vaccines against infections of hepatitis C viruses
10/24/2000US6136526 Use of human neutrophil lipocalin (HNL) as a diagnostic marker and anti-HNL-antibody preparation
10/24/2000US6136324 Deactivating tuberculosis gene
10/24/2000US6136323 Forming immunology response
10/24/2000US6136322 Genetic engineering
10/24/2000US6136320 Orally acceptable immunogenic composition
10/24/2000US6136318 Genetic engineering
10/24/2000US6136315 Compositions and methods using complexes of heat shock protein 70 and antigenic molecules for the treatment and prevention of neoplastic diseases
10/24/2000US6136314 Histone fusion protein
10/24/2000US6136313 Processes and intermediates for synthetic antibody derivatives
10/24/2000US6136269 Combinatorial kit for polymer synthesis
10/24/2000US6136040 Animal model with disrupted FGF-9 gene
10/24/2000US6135942 Nucleotide sequences of a drosophilia melanogaster insulin-like gene, the amino acid sequences of the encoded protein, and derivatives, e.g., fragments, and analogs; identifying modified genes; participate in signal transduction
10/24/2000US6135941 Human immune system associated molecules
10/24/2000CA2221148C Muscle trophic factor
10/24/2000CA2147541C Preparation process of a natural protein sweetener
10/24/2000CA2139664C Covalent polar lipid-peptide conjugates for biological targeting
10/24/2000CA2061569C Improved activation of recombinant proteins
10/24/2000CA2047702C Serpin resistant chymotrypsin superfamily proteases particularly pai-1 resistant t-pa, complementary inhibitor mutants; compositions; genes; expression
10/24/2000CA2005955C Synthetic hiv-like peptides, their compositions and uses
10/24/2000CA1341125C Dna encoding serotonin 1c (5ht1c) receptor, isolated 5ht1c receptor, mammalian cells expressing same and uses thereof
10/24/2000CA1341124C Genetic engineering process for the preparation of hirudins, and means for carrying out this process
10/20/2000CA2271451A1 Variant c-terminal fragment of plasmodium falciparum msp-1
10/19/2000WO2000062068A1 Method to type prion proteins
10/19/2000WO2000062067A1 Novel transduction molecules and methods for using same
10/19/2000WO2000062065A1 Complex formed by n-linked glycoproteins (siblings) and factor h
10/19/2000WO2000062063A1 Methods for the diagnosis and treatment of metastatic prostate tumors
10/19/2000WO2000061813A1 A second mammalian tankyrase
10/19/2000WO2000061794A1 Methods and compositions involving posttranslational modification of herpesvirus protein us1.5
10/19/2000WO2000061793A2 Novel method for identifying antibacterial compounds
10/19/2000WO2000061792A1 Novel essential bacterial genes and their proteins
10/19/2000WO2000061788A2 Poly(dipeptide) as a drug carrier
10/19/2000WO2000061782A1 Ecotine derivatives
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061772A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000WO2000061768A2 Preparation of biologically active molecules
10/19/2000WO2000061762A1 RECOMBINANT TOXIN A/TOXIN B VACCINE AGAINST $i(CLOSTRIDIUM DIFFICILE)
10/19/2000WO2000061761A2 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
10/19/2000WO2000061760A1 Piromyces equi carbohydrate binding domains
10/19/2000WO2000061759A1 Protein sweetener
10/19/2000WO2000061758A1 Viral variants
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
10/19/2000WO2000061756A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061753A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/19/2000WO2000061752A2 Modified complement system regulators
10/19/2000WO2000061751A1 REAGENTS AND METHODS FOR IDENTIFYING AND MODULATING EXPRESSION OF GENES REGULATED BY p21
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061749A1 Cellular protein p60 that interacts with herpesvirus regulatory proteins
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061747A2 Clasp-2 transmembrane proteins
10/19/2000WO2000061746A1 13 transmembrane protein expressed in prostate cancer
10/19/2000WO2000061745A1 Method for screening g protein-coupled receptor ligand and method for expression cloning g protein-coupled receptor
10/19/2000WO2000061744A1 Novel fetal genes
10/19/2000WO2000061743A1 Apoptosis-associated gene
10/19/2000WO2000061742A2 Treatment of cardiac power failure using s100 proteins
10/19/2000WO2000061741A1 Pcr-based cloning method
10/19/2000WO2000061738A2 Differential regulation of gene expression in oncogenic transformation
10/19/2000WO2000061737A2 Production of attenuated negative stranded rna virus vaccines
10/19/2000WO2000061735A1 Modification of plant storage reserves
10/19/2000WO2000061725A1 Method of purifying heterologous proteins
10/19/2000WO2000061724A2 Anti-bacterial vaccine compositions
10/19/2000WO2000061636A2 Aberrantly glycosylated antibodies as marker for cancer
10/19/2000WO2000061634A2 Ecotin-variant modulators of serine proteases
10/19/2000WO2000061633A1 Method for purifying blood coagulation factor viii and blood coagulation factor viii/von willebrand factor complex
10/19/2000WO2000061632A1 Interaction of mhc class ii proteins with members of the pcna family of proteins
10/19/2000WO2000061630A1 Induction of kidney tubule formation
10/19/2000WO2000061629A1 49 human secreted proteins
10/19/2000WO2000061628A1 49 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061626A1 49 human secreted proteins
1 ... 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 ... 2916